Jyothy Laboratories Limited announced consolidated earnings results for the third quarter and nine months ended December 31, 2016. For the quarter, the company reported net sales of INR 3,995 million against INR 3,877 million a year ago. Operating EBITDA was INR 509 million against INR 536 million a year ago. PAT was INR 215 million against INR 202 million a year ago. EPS was INR 1.18 against INR 1.11 a year ago. Cash profit was INR 282 million against INR 298 million a year ago. For the nine months, the company reported net sales of INR 12,870 million against INR 12,136 million a year ago. Operating EBITDA was INR 1,960 million against INR 1,781 million a year ago. PAT was INR 994 million against INR 658 million a year ago. EPS was INR 5.48 against INR 3.63 a year ago. Cash profit was INR 1,220 million against INR 1,058 million a year ago.